6 ms·
Show HN: Covid-19 Treatment Dashboard
- aaossa 7y agoHey, this looks really good! Didn't even know that the information about those studies was accesible. I don't understand the phases meaning, can you explain them? Maybe a table or tooltip somewhere could help.
- greatwave1 7y agoThank you very much! That’s a good idea... I will think about the best way to incorporate that information on this dashboard, but for now you can find it at https://www.nccn.org/patients/resources/clinical_trials/phases.aspx https://www.nccn.org/patients/resources/clinical_trials/phas...
- aquadrop 7y agoThanks for the site. Bug report: Looks like sort by expected finish works on strings instead of dates.
- projektfu 7y agoLooks cool. There's a lot of double entries. Is that in the data or is it a glitch?
- erinaceousjones 7y agoMinor bugbear: the thin font used does not lend itself to rendering nicely in Firefox 74 running on a GNOME 3.36 linux install with subpixel font antialiasing: https://i.imgur.com/LauxkrQ.jpg https://i.imgur.com/LauxkrQ.jpg I made it more readable it for myself by switching to grayscale antialiasing, but it's still not a very readable font as it's quite small and thin and is light-ish blue against dark-ish blue background - standard sans serif, slightly larger and with more contrast in colours probably better for accessibility
- dcre 7y agoEven when it renders properly it's still not very easy to read.
- greatwave1 7y agoThanks for the heads-up. Changed the table fonts to Verdana, hopefully they're easier to read now.
- deweller 7y agoI noticed that this study is not on the list: https://clinicaltrials.gov/ct2/show/NCT04264533 https://clinicaltrials.gov/ct2/show/NCT04264533 What is the criteria for choosing studies that show on this list?
- notaharvardmba 7y agoAlso the University of Minnesota Losartan trial: https://clinicaltrials.gov/ct2/show/NCT04312009 https://clinicaltrials.gov/ct2/show/NCT04312009 Probably don't have to look far to find another dozen or so.
- deleted 7y ago[deleted]
- hitchhiker999 7y agoFirst thing I checked, sadly missing considering the amount of medical field data on it coming out of China/East.
- svetlins 7y agoSorting by expected finish date seems be broken - it sorts by strings
- rodcoelho 7y agocame here to say this
- brian_herman__ 7y agoGreat job you should make the lists scrollable but it looks great !
- StavrosK 7y agoThis is great, is there any information somewhere about the efficacy of each treatment? I'm on mobile and may have missed it.
- chimichangga 7y agoFDA: emergency use authorization for hydroxychloroquine and chloroquine https://www.fda.gov/media/136534/download https://www.fda.gov/media/136534/download
- sbuttgereit 7y agoYep, and this possibility has become a right cluster-fuck for many people that have other needs for the drug. Many Lupus sufferers can no longer get this because of possible use (https://www.kqed.org/science/1960404/at-kaiser-trumps-pharmaceutical-advice-creates-chaos-for-lupus-patients https://www.kqed.org/science/1960404/at-kaiser-trumps-pharma...) I know people that have this condition and have been told there's none available at pharmacies when in fact it's in stock (based on how they resolved their problem).
- wrycoder 7y agoAnd how did they resolve their problem?
- jsight 7y agoThey asked until they reached the right person? Its not that uncommon of a pattern, sadly.
- sbuttgereit 7y agoBasically this.
- KarlKemp 7y agoHere’s a bit on that French doctor who started this particular craze: https://slate.com/news-and-politics/2020/03/didier-raoult-hydroxychloroquine-plaquenil.html https://slate.com/news-and-politics/2020/03/didier-raoult-hy... He doesn’t believe in evolution, nor climate change. At the end of January, he called warnings of a pandemic „crazy“. He has published 3000 papers in the last ten years. And even the photo of him is quite funny if you followed the news in 2016. Judging by the list of trials, an awful lot of resources is spent on this. I wonder what the opportunity costs are.
- dchichkov 7y agoAs per www.worldometers.info, Russia seem to have relatively low death rate (0.06 per million of population), despite having a border with China, no early distancing measures, public transportation in the cities, etc. Could be just accident, but they did one interesting thing - recommended a nation-wide treatment strategy early on.
- AdamN 7y agoThe confirmed cases number is effectively useless without models for extrapolating into an estimated infection count. Presumptive cases aren't bothering to be tested, asymptomatic cases rarely tested, lack or abundance of supplies differ by country and region, etc... We have very little idea of the prevalence in any given country - confirmed case count is just a floor.
- dchichkov 7y agoIf you notice, I'm talking about number of deaths, not the number of cases. I do understand the limitations of confirmed cases stats.
- Leary 7y agoRussia shut its border with China super early, which helped. However, it better be careful now now that its population is unprepared mentally for a potential outbreak seeded by European travelers weeks ago.
- dchichkov 7y agoAs far as I understand the mentalitet there, you don't have to worry too much.
- groby_b 7y agoMaking this information accessible is amazing work, thank you! But, alas, it loses a lot in the UX department: 1) It's low-contrast. This makes it hard to read for a lot of people, unnecessarily so. 2) It uses a font that is hard to read. Not sure if it's font rendering, or if the font is just bad, but... just a plain Sans Serif would be fine? 3) The gradient for the map is pretty much not fulfilling any function, because you can't read it with any kind of precision. You'd be better off with 4 distinct gradients. Or better, separate colors. 4) If I can nitpick: The title has 3 different font faces, with misaligned baselines. Please don't do that :)
- airstrike 7y agoIronically, the scale legend in the chart actually uses a font that's very easy to read
- vikramkr 7y agoI wonder if the thinking was to make it deliberately uninviting and difficult like the Bloomberg terminal to make people feel cooler while using it (which is a legitimate thing - i'm not saying that glibly at all. People that master the bloomberg terminal feel like wizards which certainly contributes to lockin, and that sort of needlessly difficult UX is somehow associated with being "cool" or being like a "real command center" somehow)
- fermienrico 7y agoWhile I agree with the GP, I don't agree with the jab at Bloomberg terminal. There is nothing needless in Bloomberg terminal - it comes with a special keyboard and everything is keyboard driven. There are no animations such as the ones you see in macOS and Windows that take up 300ms. There are no distracting popups and notifications. It is probably the most incredible feat of UI/UX design...ever, perhaps airplane cockpits and nuclear power plant control rooms would rival. Just because UI is dense does not mean it is not easy to learn. Dense UI provides more information than something with 5 levels of hierarchical layouts, each screen animating with 300ms of bullshit animations. Furthermore, learning curve should be acceptable for people that truly want to use a tool on a daily basis (for e.g. emacs or vim). There is a reason why people who use Bloomberg terminal will never want anything else. Here is a video of the thought process that goes into designing just the keyboard: https://www.youtube.com/watch?v=_juj1MIRJVE https://www.youtube.com/watch?v=_juj1MIRJVE Have you used Bloomberg terminal or talked to a user? Regarding lock-in: I think its the opposite - when the users don't want to switch to anything else, that's the best a company can do. That's the kind of "lock-in" every company should aspire to.
- airstrike 7y agoThe table "News articles on COVID-19 Treatments" shows a duplicate "FDA authorizes chloroquine for use in treating coronavirus"
- foobaw 7y agoMinor feedback - I wish I could click on a trial on a map to go to that trial page.
- superasn 7y agoAll I see is a login page?